Webinar

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

How to choose the most promising drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#Cell and gene therapy #Drug development #Drug discovery #Webinar

Webinar: Transforming disease treatment with CGT

Register to attend Cell and gene therapy: sustaining growth and maximising opportunities, a free-to-attend DDW webinar, supported by Benchling and BPS Bioscience, on February 17, 2023 at 8am PST / 11am EST / 4pm GMT / 5pm CET.  Cell and gene therapies (CGT) are transforming the way diseases… Read More

#News

#Cell and gene therapy #Drug development #Drug discovery #Webinar

Learn about sustaining growth and maximising opportunities in CGT

Cell and gene therapies (CGT) are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will offer innovation for the future. Join this free webinar, hosted by DDW and supported by BPS Bioscience and Benchling, to learn… Read More

#News

Human cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing #Webinar

Event: Using native state cells to uncover true biological targets

Extensive manipulation, mechanical force and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is the identification of drug targets that are not relevant to the biological process under study.  Camila Egidio Based on Nakhoda and Olszanski,… Read More

Webinar date:
Brought to you by LevitasBio
#News

Human cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing #Webinar

Why native state cells are needed to uncover true drug targets

Extensive manipulation, mechanical force and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is the identification of drug targets that are not relevant to the biological process under study.  Camila Egidio Based on Nakhoda and Olszanski,… Read More

Webinar date:
Brought to you by LevitasBio
#News

Human cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing #Webinar

Webinar: How single-cell RNA seq has advanced drug discovery

Extensive manipulation, mechanical force and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is the identification of drug targets that are not relevant to the biological process under study.  Camila Egidio Based on Nakhoda and Olszanski,… Read More

Webinar date:
Brought to you by LevitasBio
#News

Human cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing #Webinar

An overview of single-cell RNA sequencing for drug discovery

Extensive manipulation, mechanical force and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is the identification of drug targets that are not relevant to the biological process under study.  Camila Egidio Based on Nakhoda and Olszanski,… Read More

Webinar date:
Brought to you by LevitasBio
#News

Healthy cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing #Webinar

Unperturbed, native state cells uncover biological targets

Extensive manipulation, mechanical force and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is the identification of drug targets that are not relevant to the biological process under study.  Camila Egidio Based on Nakhoda and Olszanski,… Read More

Webinar date:
Brought to you by LevitasBio
#News

Cell and gene therapies
#Cell and gene therapy #mRNA #pDNA #Webinar

Early phase support for plasmid DNA supply to secure future manufacturing

One critical bottleneck in Cell and Gene Therapy (CGT) manufacturing is the production of high-quality plasmid DNA (pDNA), a vital building block for mRNA-based vaccines, viral vector-based cell or gene therapies that require pDNA as a starting material. Building a robust supply of GMP-grade pDNA requires that quality be a… Read More

Webinar date:
Brought to you by Catalent
#Webinars

Neurons in the brain
#Drug discovery #In vitro assays #Multiple sclerosis #Neurodegenerative disorders #Neuronal damage #Target identification #Webinar

Webinar: Innovative assays for neurodegeneration drug discovery

Neurodegenerative diseases are characterised by neuronal damage, degradation of the blood-brain barrier and failures in the normal repair mechanisms of the brain. Many of the most promising areas of drug development in this field target neuroinflammation and remyelination. In this new on-demand webinar we use multiple sclerosis as a case-study… Read More

Webinar date:
Brought to you by Malvern Panalytical
#News

Neurons in the brain
#Drug discovery #In vitro assays #Multiple sclerosis #Neurodegenerative disorders #Neuronal damage #Target identification #Webinar

Innovative assays for neurodegeneration drug discovery programs

Neurodegenerative diseases are characterised by neuronal damage, degradation of the blood-brain barrier and failures in the normal repair mechanisms of the brain. Many of the most promising areas of drug development in this field target neuroinflammation and remyelination. In this on-demand webinar, presented by Dr Elise Malavasi, Principal Scientist at… Read More

Webinar date:
Brought to you by Malvern Panalytical
#Webinars

Cell and gene therapy
#Bioproduction #Cell and gene therapy #mRNA #mRNA-based vaccines #pDNA #Plasmid DNA #Webinar

Webinar: How to resolve barriers to CGT discovery

Stream this free webinar, hosted by DDW and supported by Catalent, Early phase support for plasmid DNA supply helps secure future manufacturing for advanced therapies. The webinar was presented by Matthias Craig, Senior Manager Product Development, Catalent. One critical bottleneck in Cell and Gene Therapy (CGT) manufacturing is the production… Read More

#News

#CRISPR #Engineered cells #Target discovery #Target identification #Target validation #Webinar

Reveal the best drug targets with Engineered Cell Libraries

Kevin Holden Join DDW and Synthego for this free exclusive event today at 3pm GMT. Kevin Holden, Ph.D, Head of Science, Synthego will explain how the company’s engineered cell libraries enable screening more widely and efficiently to increase the pace and impact of target discovery. Register now to hear speakers Kevin Holden and… Read More

#News

Cell and gene therapy
#Bioproduction #Cell and gene therapy #mRNA #mRNA-based vaccines #pDNA #Plasmid DNA #Webinar

Webinar: Overcome barriers to CGT innovation

Watch this free webinar, hosted by DDW and supported by Catalent, which will be presented by Matthias Craig, Senior Manager Product Development, Catalent. One critical bottleneck in Cell and Gene Therapy (CGT) manufacturing is the production of high-quality plasmid DNA (pDNA), a vital building block for mRNA-based vaccines, viral vector-based… Read More

#News

#Bioproduction #Cell and gene therapy #mRNA #mRNA-based vaccines #pDNA #Plasmid DNA #Webinar

Exclusive webinar: How to remove the barriers to CGT innovation

One critical bottleneck in Cell and Gene Therapy (CGT) manufacturing is the production of high-quality plasmid DNA (pDNA), a vital building block for mRNA-based vaccines, viral vector-based cell, or gene therapies that require pDNA as a starting material.  Watch this free webinar – Early phase support for plasmid DNA supply… Read More

#News

Gene editing
#CRISPR #Engineered cells #Target discovery #Target identification #Target validation #Webinar

Using engineered cell libraries to reveal the best drug targets

Kevin Holden In this webinar, hosted by DDW and supported by Synthego, Kevin Holden, Ph.D, Head of Science, Synthego will explain how the company’s engineered cell libraries enable screening more widely and efficiently to increase the pace and impact of target discovery. Join this free exclusive event on 9 November at… Read More

#News